DMAAR

Drugs Made In America Acquisition Corp Rights
DMAAR

35 hedge funds and large institutions have $887K invested in Drugs Made In America Acquisition Corp Rights in 2026 Q1 according to their latest regulatory filings, with 6 funds opening new positions, 6 increasing their positions, 10 reducing their positions, and 3 closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more first-time investments, than exits

New positions opened: | Existing positions closed:

more funds holding

Funds holding: →

less repeat investments, than reductions

Existing positions increased: | Existing positions reduced:

less capital invested

Capital invested by funds: $ → $
Holders
35
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
–
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
–
Puts
–
Net Calls
Net Calls Change

Top Buyers

1
+$19.1K
2
+$15.8K
3
+$13.8K
4
BFM
Boothbay Fund Management
New York
+$13.3K
5
COPPSERS
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
+$12.4K

Top Sellers

1
-$281K
2
-$65.4K
3
-$37K
4
Toronto Dominion Bank
Toronto Dominion Bank
Ontario, Canada
-$33.1K
5
GCL
Glazer Capital LLC
New York
-$25.4K
Name Holding Trade Value Shares
Change 		Change in
Stake
COPPSERS
26
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$7.05K
DAM
27
DLD Asset Management
New York
$6.14K
Verition Fund Management
28
Verition Fund Management
Connecticut
$5.47K
PC
29
Periscope Capital
Ontario, Canada
$4.5K
LPC
30
Lineage Point Capital
Florida
$3.02K
GF
31
Gabelli Funds
New York
$2.98K
GCIA
32
Gabelli & Co Investment Advisers
New York
$2.9K
RAM
33
Readystate Asset Management
Illinois
$2.75K
BI
34
Bulldog Investors
New Jersey
$2.62K
SG
35
StoneX Group
New York
$2.54K
HCI
36
Harraden Circle Investments
New York
–
HCM
37
Heights Capital Management
California
–
SSA
38
Schonfeld Strategic Advisors
New York
–
1
2